Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known ...

Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

The US Health Resources and Services Administration (HRSA) has approved nine drugs for a pilot testing a new rebate model ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

WASHINGTON - A Senate health committee met last week to scrutinize the 340B Program, an initiative intended to foster the ...

Kansas’ Jerry Moran is part of a bipartisan group of U.S. senators working to reduce large hospital networks’ fraud and abuse ...

AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and ...

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...

If drugmakers have their way, the federal government likely ends up spending $100 billion of taxpayer funds to bail out rural hospitals.

One reason libertarians don’t trust the government is because so many well-intentioned government programs end up either ...